-
Get to know the dedicated professionals behind our success -
Linus Rweyemamu Paul
Biography
Linus Rweyemamu Paul (PhD) is a molecular geneticist and lecturer in the Department of Molecular Biology and Biotechnology at the University of Dar es Salaam (UDSM), Tanzania. He holds a PhD in Molecular Biology (2022) from UDSM, a Master’s in Molecular Biology (2016) from KU Leuven, Belgium, and a Bachelor of Science in Molecular Biology and Biotechnology (2012) from UDSM.
Dr. Rweyemamu’s research focuses on molecular genetics, particularly in cancers such as breast cancer, as well as public health, reproductive health, mental health, and behavioral sciences. His current interests include studying the genetic profiles of Tanzania’s indigenous populations, such as the Hadza, to understand their susceptibility to non-communicable diseases, including cancer, diabetes, and other genetic disorders.
He collaborates with researchers from Türkiye and the United Kingdom and has secured internal funding to support his research endeavors.
Research Interest
Molecular genetics of cancers, particularly as breast and cervical cancer
Genetic profile of indigenous populations such as the Hadza
Public health issues particularly reproductive health
Mental health and behavioral sciences
Contacts
Email:
Projects
Publications
Minja, J., Rweyemamu, L.P., Joho, A.A. et al. Prevalence of short inter-birth intervals and associated factors among women of reproductive age: evidence from a nationally representative survey in Tanzania. BMC Pregnancy Childbirth 25, 185 (2025). https://doi.org/10.1186/s12884-024-07026-5
Rweyemamu, L.P., Mbotwa, C.H., Massawe, J.I. et al. Mental distress and associated factors among undergraduate students: evidence from a cross-sectional study at the University of Dodoma, Tanzania. Discov Ment Health 4, 44 (2024). https://doi.org/10.1007/s44192-024-00098-x
Anthony Nsojo, Christopher Mbotwa, Linus Rweyemamu, Godlove Mbwanji, Frank Wilson, Lutengano George, Davance Mwasomola, Clement N Mweya, Issakwisa Mwakyula, In vitro performance of cost differentiated ceftriaxone brands against Escherichia coli: insights from a tertiary referral hospital in Mbeya, Tanzania, JAC-Antimicrobial Resistance 6 (5) 2024. dlae162, https://doi.org/10.1093/jacamr/dlae162
Mbotwa CH and Rweyemamu LP. Tobacco Use and Associated Factors Among Men in Tanzania: Further Analysis of the 2022 Tanzania Demographic and Health Survey Data. Tobacco Use Insights. 2024;17. DOI:10.1177/1179173X241259605
Rweyemamu LP, Gültaşlar BK, Akan G, Dharsee N, Namkinga LA, Lyantagaye SL, Yazici H and Fatmahan Atalar. Breast cancer in East Africa: Prevalence and spectrum of germline SNV/indel and CNVs in BRCA1 and BRCA2 genes among breast cancer patients in Tanzania. Cancer Medicine. 2023;12(3):3395-3409. DOI: https://doi.org/10.1002/cam4.5091
Adolf AC, Rweyemamu LP, Akan G, Mselle TF, Dharsee N, Namkinga LA, Lyantagaye SL, Atalar F. The interplay between XPG-Asp1104His polymorphism and reproductive risk factors elevates risk of breast cancer in Tanzanian women: A multiple interaction analysis. Cancer Medicine 2023;12(1):472-487. DOI: https://doi.org/10.1002/cam4.4914
Rweyemamu LP, Akan G, Adolf IC, Magorosa EP, Mosha IJ, Dharsee N, Namkinga LA, Lyantagaye SL, Nateri AS and Atalar F. The distribution of reproductive risk factors disclosed the heterogeneity of receptor-defined breast cancer subtypes among Tanzanian women. BMC Women's Health 2021;21(1):1-13. DOI: https://doi.org/10.1186/s12905-021-01536-6
Linus P Rweyemamu, Gokce Akan, Christopher H Mbotwa , Nazima Dharsee , Lucy A Namkinga , Sylvester L Lyantagaye, Ted F Mselle and Fatmahan Atalar. Absence of Germline BRCA1 c.68_69delAG and c.5266dupC Mutations among Hormone Receptor-negative Breast Cancer Patients: A First Impression at a Tertiary Cancer-care Facility in Tanzania. Tanz .J. Sci. 2021;47(5): 1824-1834. DOI: https://dx.doi.org/10.4314/tjs.v47i5.27
Njuguna E, Coussens G, Neyt P, Aesaert S, Storme V, Demuynck K, Vanhaeren H, Dhondt S, Van Haver Y, Paul L, Inzé D. Functional analysis of Arabidopsis and maize transgenic lines overexpressing the ADP-ribose/NADH pyrophosphohydrolase, AtNUDX7. Int. J. Dev. Biol. 2019;63:45-55. DOI: https://doi.org/10.1387/ijdb.180360mv